Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$2.12 - $4.18 $84 - $167
-40 Reduced 0.4%
10,060 $40,000
Q3 2023

Nov 13, 2023

BUY
$2.66 - $10.04 $954 - $3,604
359 Added 3.69%
10,100 $27,000
Q2 2023

Aug 04, 2023

BUY
$7.28 - $11.82 $11,211 - $18,202
1,540 Added 18.78%
9,741 $90,000
Q1 2023

May 12, 2023

BUY
$5.21 - $14.05 $854 - $2,304
164 Added 2.04%
8,201 $72,000
Q4 2022

Feb 10, 2023

SELL
$4.69 - $8.36 $136 - $242
-29 Reduced 0.36%
8,037 $40,000
Q3 2022

Nov 14, 2022

BUY
$5.7 - $8.68 $649 - $989
114 Added 1.43%
8,066 $47,000
Q2 2022

Aug 12, 2022

BUY
$5.04 - $14.05 $11,279 - $31,443
2,238 Added 39.17%
7,952 $44,000
Q1 2022

May 13, 2022

SELL
$8.75 - $14.51 $3,517 - $5,833
-402 Reduced 6.57%
5,714 $66,000
Q4 2021

Feb 11, 2022

BUY
$8.98 - $20.09 $54,921 - $122,870
6,116 New
6,116 $78,000

Others Institutions Holding THRX

About Theseus Pharmaceuticals, Inc.


  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.